Managers welcome US health bill

Historic decision is expected to improve the prospects for many US biotech and pharmaceutical companies

Fund managers have hailed the approval of the healthcare reform bill in the US as a significant step in removing uncertainty plaguing the sector for the past two years. US investors and sector specialists say the result offers more visibility on the future of healthcare provision. However, there are still a number of legislative hoops and political horse-trading ahead before President Barack Obama can sign his sweeping welfare reform into law. “Even back in August last year, it became clear the plan being thrashed out was going to target the healthcare insurance sector rather than the...